It doesn't appear that Nic is willing to take that route. Although we all find his attitude frustrating, it is quite apparent that he still clings to his "next Amgen" idea, and apparently the BOD supports him.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.